HSAC2

Health Sciences Acquisitions Corporation 2 ("HSAC2") is a blank check company incorporated as an exempted company in the Cayman Islands on May 25, 2020. HSAC2 was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses.HSAC2 is expected to target companies positioned in North America or Europe that are conducting research and development in the biopharmaceutical and medical technology fields, which aligns with HSAC2's management team's experience in healthcare investment and drug development.